EXOME

all the information, none of the junk | biotech • healthcare • life sciences

$9M for SynapDx

Waltham, MA-based SynapDx,a developer of diagnostic technology for the early detection of autism, announced it has completed a $9 million Series A financing, with backing from Bain Capital, General Catalyst Partners, and North Bridge Venture Partners. The startup was founded by Stanley Lapidus, an entrepreneur known for starting life sciences companies such as Helicos BioSciences (NASDAQ: HLCS) and Exact Sciences (NASDAQ: EXAS).